Sarissa Capital Management LP
Insider CIK 1577524 · APRI 10% owner · INVA 10% owner · IRWD Director, 10% owner · RGLS 10% owner · ITRM 10% owner · SRSA 10% owner · VVUS
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2025-12-15 | 2025-12-17 | 4,178 | — | $0 | 251,858 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2025-06-13 | 2025-06-17 | 24,193 | — | $0 | 235,962 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2025-06-10 | 2025-06-12 | 45,000 | — | $0 | 211,769 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2025-04-02 | 2025-04-04 | 10,416 | — | $0 | 166,769 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2025-03-06 | 2025-03-06 | 1,196,746 | $17.52 | $20.97M | 5,658,705 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2025-03-05 | 2025-03-06 | 270,374 | $17.63 | $4.77M | 6,855,451 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2025-03-04 | 2025-03-06 | 151,175 | $17.63 | $2.67M | 7,125,825 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-12-16 | 2024-12-18 | 4,249 | — | $0 | 156,353 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-09-16 | 2024-09-18 | 3,282 | — | $0 | 152,104 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-06-18 | 2024-06-21 | 24,311 | — | $0 | 148,822 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-06-15 | 2024-06-18 | 2,572 | — | $0 | 124,511 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-03-15 | 2024-03-19 | 1,662 | — | $0 | 121,939 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-12-15 | 2023-12-19 | 1,347 | — | $0 | 120,277 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-09-15 | 2023-09-19 | 1,798 | — | $0 | 118,930 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-06-20 | 2023-06-22 | 22,350 | — | $0 | 117,132 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-06-15 | 2023-06-20 | 1,359 | — | $0 | 94,782 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-06-15 | 2023-06-20 | 62,000 | $13.13 | $814.1K | 7,277,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-06-06 | 2023-06-07 | 8,000 | $13.05 | $104.4K | 7,215,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-06-05 | 2023-06-07 | 7,000 | $13.04 | $91.3K | 7,207,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-30 | 2023-05-30 | 120,000 | $13.01 | $1.56M | 7,200,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-26 | 2023-05-30 | 30,000 | $13.12 | $393.6K | 7,080,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-25 | 2023-05-30 | 50,000 | $13.09 | $654.5K | 7,050,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-19 | 2023-05-19 | 36,000 | $13.48 | $485.3K | 7,000,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-18 | 2023-05-19 | 10,000 | $13.05 | $130.5K | 6,964,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-18 | 2023-05-19 | 10,000 | $13.05 | $130.5K | 6,964,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-17 | 2023-05-19 | 50,000 | $13.07 | $653.5K | 6,954,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-17 | 2023-05-19 | 50,000 | $13.07 | $653.5K | 6,954,000 | SEC↗ |
| INVA Innoviva, Inc. | P Buy | 2023-05-11 | 2023-05-15 | 290,000 | $12.34 | $3.58M | 6,904,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-03-15 | 2023-03-17 | 1,438 | — | $0 | 93,423 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-12-15 | 2022-12-19 | 1,244 | — | $0 | 91,985 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-09-15 | 2022-09-19 | 1,374 | — | $0 | 90,741 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-06-15 | 2022-06-17 | 1,222 | — | $0 | 89,367 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-06-01 | 2022-06-03 | 21,571 | — | $0 | 88,145 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-03-15 | 2022-03-17 | 1,152 | — | $0 | 66,574 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-12-15 | 2021-12-17 | 1,211 | — | $0 | 65,422 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-09-15 | 2021-09-17 | 1,137 | — | $0 | 64,211 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-06-15 | 2021-06-16 | 1,229 | — | $0 | 63,074 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-06-02 | 2021-06-04 | 22,766 | — | $0 | 61,845 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-03-15 | 2021-03-17 | 1,235 | — | $0 | 39,079 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-10 | 2021-03-10 | 75,000 | $10.54 | $790.5K | 16,390,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-08 | 2021-03-10 | 150,000 | $10.30 | $1.54M | 16,315,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-05 | 2021-03-05 | 175,000 | $10.01 | $1.75M | 16,165,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-04 | 2021-03-05 | 250,000 | $10.00 | $2.50M | 15,990,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2021-03-03 | 2021-03-05 | 350,000 | $10.02 | $3.51M | 15,740,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2021-02-12 | 2021-02-12 | 10,619,949 | $2.27 | $24.11M | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2021-02-11 | 2021-02-12 | 15,000,000 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2021-02-11 | 2021-02-12 | 10,000,000 | $2.59 | $25.90M | 10,619,949 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2021-02-11 | 2021-02-12 | 20,619,949 | — | $0 | 20,616,949 | SEC↗ |
| SRSA Sarissa Capital Acquisitio | J Other deriv | 2020-10-30 | 2020-11-03 | 31,250 | — | $0 | 5,000,000 | SEC↗ |
| SRSA Sarissa Capital Acquisitio | P Buy deriv | 2020-10-23 | 2020-10-23 | 3,333,333 | $1.50 | $5.00M | 3,333,333 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2020-01-03 | 423,162 | — | $0 | 423,162 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2020-01-03 | 4,231,620 | — | $0 | 6,083,471 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | J Other deriv | 2018-03-21 | 2018-03-23 | 653,409 | — | $0 | 0 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | J Other deriv | 2018-03-21 | 2018-03-23 | 653,409 | — | $0 | 653,409 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy deriv | 2017-08-31 | 2017-09-01 | 2,835 | — | $0 | 672,453 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy | 2017-08-31 | 2017-09-01 | 6,104 | $1.63 | $9.9K | 1,447,906 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy deriv | 2016-03-03 | 2016-03-07 | 3,323,864 | — | $0 | 6,724,525 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy | 2016-03-03 | 2016-03-07 | 6,647,728 | $0.88 | $5.85M | 14,479,053 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy deriv | 2016-01-12 | 2016-01-14 | 653,409 | — | $0 | 3,400,661 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy | 2016-01-12 | 2016-01-14 | 1,306,819 | $0.88 | $1.15M | 7,831,324 | SEC↗ |